SEP 9, 2026 · JOURNAL ARTICLE
Combined C-reactive protein, procalcitonin, and microalbuminuria panel for contrast-induced nephropathy risk stratification after percutaneous coronary intervention
Frontiers in Cardiovascular Medicine
A retrospective single-centre study of 486 patients demonstrating that a three-biomarker panel outperforms existing risk scores for a surrogate endpoint (serum creatinine change), with clear effect sizes but requiring prospective validation and generalization to cardio-oncology populations.
Reported
CIN incidence92/486 (18.9%)
CRP >10 mg/L odds ratio3.15
CRP odds ratio p-valuep < 0.001